XML 87 R6.htm IDEA: XBRL DOCUMENT v3.19.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net (loss) income $ (42,750) $ 3,697
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 82,919 79,752
Noncash lease expense 2,299 0
Amortization of debt issuance costs 3,296 3,184
Deferred Purchase Price Obligation 11,899 53,759
Unit-based and noncash compensation 5,370 6,188
Loss from equity method investees 1,197 3,703
Distributions from equity method investees 28,008 26,528
Gain on asset sales, net (1,595) (6)
Long-lived asset impairment 45,021 2,127
Goodwill impairment 16,211 0
Changes in operating assets and liabilities:    
Accounts receivable 8,363 (11,557)
Trade accounts payable 821 (2,991)
Accrued expenses (12,193) 5,848
Due to affiliate (98) (1,075)
Deferred revenue, net 1,910 5,160
Ad valorem taxes payable (2,061) (106)
Accrued interest 3,081 2,975
Accrued environmental remediation, net (2,025) (3,060)
Other, net (6,254) (7,634)
Net cash provided by operating activities 143,419 166,492
Cash flows from investing activities:    
Capital expenditures (151,663) (137,033)
Proceeds from asset sale (net of cash of $1,475 for the nine months ended September 30, 2019) 90,111 496
Distributions from equity method investment 7,252 0
Investment in equity method investee (11,330) 0
Other, net 343 (209)
Net cash used in investing activities (65,287) (136,746)
Cash flows from financing activities:    
Distributions to unitholders (92,833) (135,484)
Borrowings under Revolving Credit Facility 265,000 202,000
Repayments under Revolving Credit Facility (131,000) (79,000)
Repayment of Deferred Purchase Price Obligation (100,000) 0
Debt issuance costs (413) (334)
Other, net (3,931) (3,738)
Net cash used in financing activities (77,427) (30,806)
Net change in cash and cash equivalents 705 (1,060)
Cash and cash equivalents, beginning of period 4,345 1,430
Cash and cash equivalents, end of period 5,050 370
Supplemental cash flow disclosures:    
Cash interest paid 54,100 44,126
Less capitalized interest 5,752 5,536
Interest paid (net of capitalized interest) 48,348 38,590
Cash paid for taxes 150 175
Noncash investing and financing activities    
Capital expenditures in trade accounts payable (period-end accruals) 22,166 20,977
Asset contribution to an equity method investment 23,643 0
Series A Preferred Units    
Cash flows from financing activities:    
Distributions to unitholders (14,250) (14,250)
Topic 606    
Noncash investing and financing activities    
Capital expenditures relating to contributions in aid of construction for day 1 adoption 0 33,123
Topic 842    
Noncash investing and financing activities    
Right-of-use assets relating to Topic 842 $ 5,448 $ 0